Lyell Immunopharma EPS Diluted from Extraordinaries (Quarterly) Trends

Lyell Immunopharma, Inc. (LYEL)

22.59 +1.19 (+5.56%) USD | NASDAQ | Feb 23, 16:00

22.59 0.00 (0.00%) After-Hours: 19:59

View EPS Diluted from Extraordinaries (Quarterly) for LYEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Nektar Therapeutics	--
GT Biopharma, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Vertex Pharmaceuticals, Inc.	--